Patent application number | Description | Published |
20090300098 | SYNDICATING ENTERPRISE APPLICATION SYSTEM DATA - Systems and methods are provided that syndicate enterprise application system (EAS) data. A method includes creating a feed for an EAS module, generating a news item for the feed, and publishing the news item on the feed. Accordingly, employees in an organization are able to easily become aware of information about their organization by tightly coupling a syndication system to human resources management. The sharing of information throughout the organization creates a more inclusive and cohesive working environment. In one embodiment, the EAS data is enterprise resource planning (ERP) data. | 12-03-2009 |
20090319595 | Presence Mapping - Systems, methods, and associated software for detecting presence are described with respect to a number of embodiments of the present disclosure. More particularly, presence information can be displayed on a floor plan, according to the teachings herein. In one implementation, a method for monitoring the presence of a person is described in which the name of a person of interest is received from a requestor. The requestor and the person of interest are both associated with an organization. The method also includes retrieving information regarding a first work area associated with the person of interest and reproducing a section of a floor plan containing at least the first work area. Furthermore, the method includes sending the section of the floor plan to the requestor. The method also includes retrieving information regarding the person of interest associated with the first work area. A name field, which includes the name and the presence status of the person of interest, is sent to the requestor. | 12-24-2009 |
20100005085 | CREATING RELATIONSHIP MAPS FROM ENTERPRISE APPLICATION SYSTEM DATA - Systems and methods are provided that create a relationship map using enterprise application system (EAS) data. Relationship data is automatically collected from EAS modules. The EAS modules may be enterprise resource planning (ERP) modules. A relationship map is then generated from the collected relationship data. Thus, a representation of formal and informal working relationships among employees in an organization is built, where such relationship data was previously too onerous to capture manually. Further, this representation may be visually illustrated to a user, enabling the user to navigate among the relationships of their fellow coworkers. | 01-07-2010 |
20100005098 | COMBINED DIRECTORY OF PERSONAL AND ENTERPRISE APPLICATION SYSTEM DATA - Systems and methods are provided that combine private contact information and Enterprise Application System (“EAS”) data in a directory. An embodiment includes receiving private contact information regarding a first employee from a second employee, storing the private contact information regarding the first employee on an EAS server, and displaying the private contact information to the second employee upon request, wherein the private contact information is viewable only to the second employee. | 01-07-2010 |
20100011361 | Managing Task Requests - Systems and methods are disclosed herein for managing task requests. An end user device include one or several possible implementation for managing task requests. Specifically, the end user device comprises a processing device and a memory device, which is configured to store a task request managing program. The processing device is configured to execute the task request managing program. The processing device is configured to analyze a string of characters of a natural language request from a user to extract a requested task and a requested object. The processing device is further configured to check whether the user is permitted to initiate the requested task on the requested object. In addition, the processing device is configured to perform the requested task on the requested object when it is determined that the user is permitted to initiate the requested task on the requested object. | 01-14-2010 |
Patent application number | Description | Published |
20110055755 | Method and System for Displaying Group Relationships in a Graphical User Interface - The present invention is directed to a method and system for providing a user interface representing organization hierarchy wherein a group of entities can be displayed as a node, and the node is displayed as a part of a hierarchical chart. In various embodiments, the present invention provides a graphical user interface displaying nodes that represent groups of entities, and the nodes are displayed as a part of a hierarchical chart based on the hierarchical relationship among the nodes that represent groups of entities. In various embodiments, a user is able to select actions for a group of entities displayed on the same node. Based on various criteria, nodes displaying one group of entities may, based on user selections of different grouping criteria, display a different group of entities. There are other features as well, in the graphical interface. | 03-03-2011 |
20110055756 | Method and System for Providing Graphical User Interface Having Filtering Capability - Embodiments of the present invention are directed to user interfaces and more particularly to techniques for providing user interface which allows users to select filtering lcriteria and display filtered information accordingly. In various embodiments, related information is displayed on a hierarchical chart as nodes that are connected to one another. The hierarchical chart is updated after filtering criteria are applied, and the display visibility of the nodes are changed based on the filtering results. The hierarchical relationships among the nodes are maintained before and after the filtering process. In a specific embodiment, the nodes that do not meet filtering criteria are displayed at a low visibility level on the hierarchical chart. | 03-03-2011 |
20110055768 | METHOD AND SYSTEM FOR PROVIDING GRAPHICAL USER INTERFACE WITH CONTEXTUAL VIEW - A method and system for providing a graphical user interface with contextual views. In various embodiments, the present invention provides a graphical user interface that allows the changing contents of a global menu in the graphical display based upon the selected nodes that belong to a hierarchical chart. Only those actions applicable (contextual) to the selected nodes will be determined and displayed in the menu. Accordingly, the contents of the selectable options are updated based upon the selected nodes. When more than one node is selected, the displayed selectable actions are an intersection of the actions permitted for each selected node. In a specific embodiment, a comparison menu is provided to allow the user to be able to compare unique corresponding properties of selected nodes. | 03-03-2011 |
Patent application number | Description | Published |
20110045908 | SERVING PATRONS IN A WAGERING GAME ENVIRONMENT - Systems and methods for serving patrons in a wagering game environment are described herein. In some embodiments, a method includes receiving patron service information, wherein the patron service information indicates activities of a patron in a casino. The method can also include selecting, based on the patron service information, a service for the patron, wherein the patron has not requested the service. Additionally, the method can include presenting a service order instructing a service attendant to deliver the service. | 02-24-2011 |
20110050592 | Touch-Screen User Interface - A user interface for a touch-screen display of a dedicated handheld electronic book reader device is described. The user interface detects human gestures manifest as pressure being applied by a finger or stylus to regions on the touch-screen display. In one implementation, the touch-screen user interface enables a user to turn one or more pages in response to applying a force or pressure to the touch-screen display. In another implementation, the touch-screen user interface is configured to bookmark a page temporarily by applying a pressure to the display, then allowing a user to turn pages to a new page, but reverting back to a previously-displayed page when the pressure is removed. In another implementation, the touch-screen user interface identifies and filters electronic books based on book size and/or a time available to read a book. In another implementation, the touch-screen user interface converts text to speech in response to a user touching the touch-screen display. | 03-03-2011 |
20110050593 | Touch-Screen User Interface - A user interface for a touch-screen display of a dedicated handheld electronic book reader device is described. The user interface detects human gestures manifest as pressure being applied by a finger or stylus to regions on the touch-screen display. In one implementation, the touch-screen user interface enables a user to turn one or more pages in response to applying a force or pressure to the touch-screen display. In another implementation, the touch-screen user interface is configured to bookmark a page temporarily by applying a pressure to the display, then allowing a user to turn pages to a new page, but reverting back to a previously-displayed page when the pressure is removed. In another implementation, the touch-screen user interface identifies and filters electronic books based on book size and/or a time available to read a book. In another implementation, the touch-screen user interface converts text to speech in response to a user touching the touch-screen display. | 03-03-2011 |
20110050594 | Touch-Screen User Interface - A user interface for a touch-screen display of a dedicated handheld electronic book reader device is described. The user interface detects human gestures manifest as pressure being applied by a finger or stylus to regions on the touch-screen display. In one implementation, the touch-screen user interface enables a user to turn one or more pages in response to applying a force or pressure to the touch-screen display. In another implementation, the touch-screen user interface is configured to bookmark a page temporarily by applying a pressure to the display, then allowing a user to turn pages to a new page, but reverting back to a previously-displayed page when the pressure is removed. In another implementation, the touch-screen user interface identifies and filters electronic books based on book size and/or a time available to read a book. In another implementation, the touch-screen user interface converts text to speech in response to a user touching the touch-screen display. | 03-03-2011 |
Patent application number | Description | Published |
20080267971 | Antibodies Directed to Angiopoietin-2 and Uses Thereof - Antibodies directed to the antigen Ang-2 and uses of such antibodies are described. In particular, fully human monoclonal antibodies directed to the antigen Ang-2. Nucleotide sequences encoding, and amino acid sequences comprising, heavy and light chain immunoglobin molecules, particularly sequences corresponding to contiguous heavy and light chain sequences spanning the framework regions and/or complementary determining regions (CDR's), specifically from FR1 through FR4 or CDR1 through CDR3. Hybridomas or other cell lines expressing such immunoglobin molecules and monoclonal antibodies. | 10-30-2008 |
20090252746 | ERYTHROPOIETIN RECEPTOR BINDING ANTIBODIES - The present invention relates to antibodies and antibody fragments thereof that bind to and activate an erythropoietin receptor. The present invention also relates to methods of modulating the endogenous activity of an erythropoietin receptor in a mammal using said antibodies as well as pharmaceutical compositions containing said antibodies. | 10-08-2009 |
20100028906 | REDUCING THE RISK OF HUMAN ANTI-HUMAN ANTIBODIES THROUGH V GENE MANIPULATION - The present embodiments relate to methods of identifying and creating human or humanized antibodies that possess a reduced risk of inducing a Human Anti-Human Antibody (HAHA) response when they are applied to a human host. Other methods are directed to predicting the likelihood of a HAHA response occurring. Methods for screening for anti-HAHA compounds are also included. Methods for determining if various conditions for administering an antibody to a subject enhance or suppress a HAHA response are also included. | 02-04-2010 |
20100040629 | Antibodies to c-Met - The present invention relates to antibodies including human antibodies and antigen-binding portions thereof that specifically bind to c-Met, preferably human c-Met, and that function to inhibit c-Met. The invention also relates to human anti-c-Met antibodies and antigen-binding portions thereof. The invention also relates to antibodies that are chimeric, bispecific, derivatized, single chain antibodies or portions of fusion proteins. The invention also relates to isolated heavy and light chain immunoglobulins derived from human anti-c-Met antibodies and nucleic acid molecules encoding such immunoglobulins. The present invention also relates to methods of making human anti-c-Met antibodies, compositions comprising these antibodies and methods of using the antibodies and compositions for diagnosis and treatment. The invention also provides gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules that comprise the human anti-c-Met antibodies. The invention also relates to transgenic animals or plants comprising nucleic acid molecules of the present invention. | 02-18-2010 |
20110091455 | ANTIBODIES TO MYOSTATIN - The present invention relates to antibodies including human antibodies and antigen-binding portions thereof that bind to myostatin, and that function to inhibit myostatin. The invention also relates to human anti-myostatin antibodies and antigen-binding portions thereof. The invention also relates to antibodies that are chimeric, bispecific, derivatized, single chain antibodies or portions of fusion proteins. The invention also relates to isolated heavy and light chain immunoglobulins derived from human anti-myostatin antibodies and nucleic acid molecules encoding such immunoglobulins. The present invention also relates to methods of making human anti-myostatin antibodies, compositions comprising these antibodies and methods of using the antibodies and compositions for diagnosis and treatment. The invention also provides gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules that comprise the human anti-myostatin antibodies. The invention also relates to transgenic animals or plants comprising nucleic acid molecules of the present invention. | 04-21-2011 |
20110274696 | ANTIBODIES TO CCR2 - Provided are antibodies including human antibodies and antigen-binding portions thereof that specifically bind to CCR2, specifically human CCR2, and that may function to inhibit CCR2. Anti-CCR2 antibodies include those which bind to the first and/or second extracellular loops of CCR2. Also provided are human anti-CCR2 antibodies and antigen-binding portions thereof. Isolated heavy and light chain immunoglobulins derived from human anti-CCR2 antibodies and nucleic acid molecules encoding such immunoglobulins are provided. Methods of making human anti-CCR2 antibodies or antigen-binding portions, compositions comprising these antibodies or antigen-binding portions, methods of using the antibodies and antigen-binding portions, and compositions for diagnosis and treatment are provided. Also provided are gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules that comprise the human anti-CCR2 antibodies or antigen binding portions thereof | 11-10-2011 |
20120219976 | REDUCING THE RISK OF HUMAN ANTI-HUMAN ANTIBODIES THROUGH V GENE MANIPULATION - The present embodiments relate to methods of identifying and creating human or humanized antibodies that possess a reduced risk of inducing a Human Anti-Human Antibody (HAHA) response when they are applied to a human host. Other methods are directed to predicting the likelihood of a HAHA response occurring. Methods for screening for anti-HAHA compounds are also included. Methods for determining if various conditions for administering an antibody to a subject enhance or suppress a HAHA response are also included. | 08-30-2012 |
20120321614 | ANTIBODIES TO C-MET - The present invention relates to antibodies including human antibodies and antigen-binding portions thereof that specifically bind to c-Met, preferably human c-Met, and that function to inhibit c-Met. The invention also relates to human anti-c-Met antibodies and antigen-binding portions thereof. The invention also relates to antibodies that are chimeric, bispecific, derivatized, single chain antibodies or portions of fusion proteins. The invention also relates to isolated heavy and light chain immunoglobulins derived from human anti-c-Met antibodies and nucleic acid molecules encoding such immunoglobulins. The present invention also relates to methods of making human anti-c-Met antibodies, compositions comprising these antibodies and methods of using the antibodies and compositions for diagnosis and treatment. The invention also provides gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules that comprise the human anti-c-Met antibodies. The invention also relates to transgenic animals or plants comprising nucleic acid molecules of the present invention. | 12-20-2012 |
20130171160 | ANTIBODIES DIRECTED TO ANGIOPOIETIN-2 AND USES THEREOF - Antibodies directed to the antigen Ang-2 and uses of such antibodies are described. In particular, fully human monoclonal antibodies directed to the antigen Ang-2. Nucleotide sequences encoding, and amino acid sequences comprising, heavy and light chain immunoglobulin molecules, particularly sequences corresponding to contiguous heavy and light chain sequences spanning the framework regions and/or complementarity determining regions (CDR's), specifically from FR1 through FR4 or CDR1 through CDR3. Hybridomas or other cell lines expressing such immunoglobulin molecules and monoclonal antibodies. | 07-04-2013 |
20130344514 | REDUCING THE RISK OF HUMAN ANTI-HUMAN ANTIBODIES THROUGH V GENE MANIPULATION - The present embodiments relate to methods of identifying and creating human or humanized antibodies that possess a reduced risk of inducing a Human Anti-Human Antibody (HAHA) response when they are applied to a human host. Other methods are directed to predicting the likelihood of a HAHA response occurring. Methods for screening for anti-HAHA compounds are also included. Methods for determining if various conditions for administering an antibody to a subject enhance or suppress a HAHA response are also included. | 12-26-2013 |
20140086914 | TREATMENT METHODS USING c-MET ANTIBODIES - The present invention relates to antibodies including human antibodies and antigen-binding portions thereof that specifically bind to c-Met, preferably human c-Met, and that function to inhibit c-Met. The invention also relates to human anti-c-Met antibodies and antigen-binding portions thereof. The invention also relates to antibodies that are chimeric, bispecific, derivatized, single chain antibodies or portions of fusion proteins. The invention also relates to isolated heavy and light chain immunoglobulins derived from human anti-c-Met antibodies and nucleic acid molecules encoding such immunoglobulins. The present invention also relates to methods of making human anti-c-Met antibodies, compositions comprising these antibodies and methods of using the antibodies and compositions for diagnosis and treatment. The invention also provides gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules that comprise the human anti-c-Met antibodies. The invention also relates to transgenic animals or plants comprising nucleic acid molecules of the present invention. | 03-27-2014 |
20140154243 | SPECIFIC BINDING AGENTS TO HEPATOCYTE GROWTH FACTOR - Specific binding agents that interact with hepatocyte growth factor (HGF) are described. Methods of treating cancer by administering a pharmaceutically effective amount of a specific binding agent to HGF are described. Methods of detecting the amount of HGF in a sample using a specific binding agent to HGF are described. | 06-05-2014 |
20140342450 | ANTIBODIES TO CCR2 - Provided are antibodies including human antibodies and antigen-binding portions thereof that specifically bind to CCR2, preferably human CCR2, and that may inhibit CCR2. The present antibodies may bind to the first and/or second extracellular loops of CCR2. Isolated heavy and light chains derived from the antibodies and nucleic acid molecules encoding the antibodies and chains are provided. Methods of making and using the anti-CCR2 antibodies or antigen-binding portions, and compositions comprising these antibodies or antigen-binding portions, including compositions for diagnosis and treatment, are provided. Also provided are gene therapy methods using nucleic acid molecules encoding the heavy and/or light chains that comprise the human anti-CCR2 antibodies or antigen-binding portions thereof. | 11-20-2014 |
20150125455 | ANTIBODIES DIRECTED TO ANGIOPOIETIN-2 AND USES THEREOF - Antibodies directed to the antigen Ang-2 and uses of such antibodies are described. In particular, fully human monoclonal antibodies directed to the antigen Ang-2. Nucleotide sequences encoding, and amino acid sequences comprising, heavy and light chain immunoglobulin molecules, particularly sequences corresponding to contiguous heavy and light chain sequences spanning the framework regions and/or complementarity determining regions (CDR's), specifically from FR1 through FR4 or CDR1 through CDR3. Hybridomas or other cell lines expressing such immunoglobulin molecules and monoclonal antibodies. | 05-07-2015 |
20150315288 | ANTIBODIES DIRECTED TO THE DELETION MUTANTS OF EPIDERMAL GROWTH FACTOR RECEPTOR AND USES THEREOF - The present invention relates to novel antibodies, particularly antibodies directed against deletion mutants of epidermal growth factor receptor and particularly to the type III deletion mutant, EGFRvIII. The invention also relates to human monoclonal antibodies directed against deletion mutants of epidermal growth factor receptor and particularly to EGFRvIII. Diagnostic and therapeutic formulations of such antibodies, and immunoconjugates thereof, are also provided. | 11-05-2015 |
Patent application number | Description | Published |
20090240647 | METHOD AND APPRATUS FOR DETECTING PATTERNS OF BEHAVIOR - Systems, apparatus, techniques, and methods are disclosed for predictively adapting properties of devices as a function of a user's historical behaviors (e.g., habits) as well as the specific context within which such behaviors are displayed. Such context can be virtually anything, such as day of the week, time of day, season, tide, temperature, weather, the user's mood, the score of a particular sporting event from the previous day, the phase of the moon, the user's location, etc. Based on observation by software, the user's habits and the context within which those habits occur are observed and the device is customized based on the user's behavioral patterns and the context thereof | 09-24-2009 |
20130173425 | CONSUMER-INITIATED FINANCIAL TRANSACTION BASED ON SALES-SIDE INFORMATION - During a financial transaction, an electronic device associated with a consumer receives an electronic package from a counterparty in the financial transaction. This electronic package includes sales-side information associated with the financial transaction. Then, the electronic device analyzes the electronic package to extract the sales-side information. Moreover, the electronic device provides the sales-side information and payment information to a third party that completes the financial transaction, thereby allowing the consumer to initiate the payment process. Next, the electronic device receives confirmation from the third party when the financial transaction has been completed. | 07-04-2013 |
20130238434 | FINANCIAL OUTCOME BASED ON SHARED FINANCIAL OBJECTS - During a financial transaction, functional representations of financial histories of users are exchanged between electronic devices, where a given functional representation specifies one or more output values based on input values. Then, one of the electronic devices identifies a subset of the group of functional representations having at least a common characteristic. For example, the characteristic may include a wide variety of attributes, such as a mathematical feature in the functional representations, a financial performance metric associated with the functional representations, a behavior relationship specified by the functional relationships, and/or a range of the one or more output values specified by the functional representations. This electronic device may provide information associated with the subset of the group of functional representations (such as an average functional representation of the subset) to the other electronic devices. | 09-12-2013 |
20130238460 | DETERMINING SHOPPING INTENT BASED ON FINANCIAL OBJECTS - During a financial transaction, a functional representation of a financial history of the user is accessed. The functional representation specifies a financial output value based on input values and a behavioral pattern, and the behavioral pattern specifies a relationship between at least a pair of the variables associated with a dimension in the financial history. Then, information about actions and activities of the user is collected, where the information corresponds to the behavioral pattern. For example, the actions may include financial transactions of the user and/or the activities may include locations of the user. Moreover, the shopping intent of the user is determined based on the information and the functional representation, where the shopping intent indicates a probability that the user intends to purchase an item (such as a product or a service) within a subsequent time interval. | 09-12-2013 |
20130238475 | GENERALIZED FINANCIAL OBJECTS - During a financial transaction, a financial history of the user is accessed. This financial history may include financial data of the user over time, and the financial data may include multiple variables in a multidimensional space. Then, a behavioral pattern of the user is identified by determining a relationship between at least a pair of the variables along a dimension in the multidimensional space. Moreover, the functional representation is generated. This functional representation specifies a financial output value based on input values and the identified behavioral pattern, where the input values include financial data for at least one of the variables. The user may use the functional representation to facilitate financial decision-making | 09-12-2013 |
20130238476 | COUNTERFACTUAL TESTING OF FINANCES USING FINANCIAL OBJECTS - During a financial transaction, a functional representation of a financial history of a user is accessed. This functional representation specifies a financial output value based on input values and a behavioral pattern, and the behavioral pattern specifies a relationship between at least a pair of the variables associated with a dimension in the financial history. Then, the functional representation is modified based on a financial circumstance that is different than financial circumstances in the financial history. Moreover, the financial output value is calculated using the functional representation and the input values, and a modified financial output value is calculated using the modified functional representation and the input values. Next, the financial output value and the modified financial output value are compared. Based on the comparison and a testing metric, the electronic device determines a result of the counterfactual testing. | 09-12-2013 |
20130238477 | SYSTEM FOR DYNAMICALLY GENERATING FINANCIAL OBJECTS - During a financial transaction, information related to a financial history of a user is collected. This information includes financial data of the user over time, and the information specifies a behavioral pattern of the user. Then, a functional representation that specifies a financial output value based on input values and the behavioral pattern is generated, where the input values include at least a portion of the financial data. Moreover, based on the financial data, the financial output value is calculated using the functional representation and input values in the information, and one or more additional financial output values are calculated using one or more additional functional representations and the input values. Next, a financial analysis is performed for the user by comparing the financial output value and the one or more additional financial output values. | 09-12-2013 |